Discovery of GPCR-active natural products and their biosynthetic genes from the human associated bacteria
Discovery of GPCR-active natural products and their biosynthetic genes from the human associated bacteria
批准号:
10229230
负责人:
SEAN F BRADY
金额:
$25.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-14 至 2022-06-30
关键词:
2019-nCoVAffectAmericanAnabolismBacteriaBiologicalBiological AssayBiological ProcessBrainChemicalsCirrhosisCollectionComplexDevelopmentDiabetes MellitusDiseaseDrug TargetingEnvironmentEukaryotic CellFamilyFractionationFundingG-Protein-Coupled ReceptorsGene ClusterGenesHealthHumanHuman BiologyHuman MicrobiomeImmune systemIndividualInflammatory Bowel DiseasesIrritable Bowel SyndromeLettersLigandsLinkMediatingMicrobeMolecular WeightMusNatural ProductsNeuraxisObesityOrganismOutcomePathway interactionsPharmacotherapyPhysiologyPlayPopulationProbioticsProcessProductionRegulationReportingRoleShapesSignal TransductionSourceStructureTherapeuticValidationVirusWorkautism spectrum disorderbasecommensal bacteriadesigngenetic manipulationhost-microbe interactionshuman diseasehuman microbiotaimmunoregulationin vivoinsightmicrobiomemicrobiome sequencingnovelnovel therapeuticspandemic diseaseparent grantpathogenprogramsreceptorscreeningsmall moleculetherapy development
中文摘要
项目摘要:受人类微生物组启发的疗法的发展至少在一定程度上受到限制
由于我们缺乏对人类相关(HA-)细菌如何与人类宿主交流的了解,
影响病原体。人类微生物组测序研究显示,
细菌种群和人类健康。尽管存在这些相关性和将HA细菌与
尽管HA细菌在小鼠中的致病性,HA细菌如何特异性地影响哺乳动物生理学的机制细节仍然存在,
大部分未知。在其他环境中,已知细菌严重依赖低分子量
化合物(小分子或天然产物)与其他生物体相互作用。同样,我们预计,
HA细菌可能使用小分子与其人类宿主和病原体相互作用。安装
有证据表明,尽管每个人体微生物组都由复杂的细菌组成,
在大多数个体中,数量少得多的物种非常普遍。虽然我们不知道
确切地说,HA细菌负责维持人类健康或引起疾病,我们假设
这些常见的HA细菌产生的小分子可能在
在这些过程中。这项建议的中心目的是筛选代谢物产生的最常见的
观察HA-细菌在高通量生物活性筛选中鉴定GPCR和SARS-CoV-2-活性小
分子及其产生生物合成基因簇(BGC)。GPCR是最大的
真核细胞跨膜受体。众所周知,它们在人类生物学中扮演着多种多样的重要角色
并且易于被小分子调节。基于GPCR在以下方面发挥如此广泛的作用这一事实,
将环境中的化学信息转化为真核细胞中的生物信号,我相信,
HA细菌可能通过产生与GPCR相互作用的小分子来影响宿主生理学。
SARS-CoV-2病毒的出现代表了一场没有治疗药物的全球性大流行
治疗。本提案的两个目的将导致(1)鉴定,分离和结构阐明
HA细菌编码的代谢产物,与不同的GPCR相互作用或抑制SARS-CoV-2,(2)
这些代谢物的基因簇的表征,和(3)通过
殖民细菌这些研究将有助于阐明HA细菌如何形成的机制细节
人体健康据报道,人类微生物组影响复杂的病理生理过程,
从免疫系统的调节到大脑和中枢神经系统的发育。
HA细菌种群的变化与影响超过2亿美国人的疾病有关
包括肥胖、糖尿病、炎症性肠病、自闭症、肠易激综合征和肝硬化,
其他许多人.来源于HA-细菌的疗法在控制多种基本生物学特性方面具有潜在的实用性。
过程和人类疾病。
英文摘要
Project summary: The development of therapies inspired by the human microbiome is at least in part limited
by our lack of understanding of how human associated (HA-) bacteria communicate with their human host and
affect pathogens. Human microbiome sequencing studies show strong correlations between changes in
bacterial populations and human health. Despite these correlations and the evidence linking HA-bacteria to
disease in mice, the mechanistic details of how HA-bacteria specifically affect mammalian physiology remain
largely unknown. In other environments, bacteria are known to rely heavily on low molecular weight
compounds (small molecules or natural products) to interact with other organisms. Similarly, we expect that
HA-bacteria are likely to use small molecules to interact with their human hosts and pathogens. Mounting
evidence suggests that, although each human microbiome is composed of a complex collection of bacteria, a
much smaller number of species is highly prevalent across the majority of individuals. While we don’t know
exactly which HA-bacteria are responsible for maintaining human health or causing disease, we hypothesize
that small molecules produced by these commonly encountered HA-bacteria are likely to play an important role
in these processes. The central aim of this proposal is to screen metabolites produced by the most commonly
observed HA-bacteria in high-throughput bioactivity screening to identify GPCR and SARS-CoV-2-active small
molecules and their producing biosynthetic gene clusters (BGCs). GPCRs constitute the largest family of
eukaryotic trans-membrane receptors. They are known to play diverse and profound roles in human biology
and are prone to regulation by small molecules. Based on the fact that GPCRs play such an extensive role in
transforming chemical information from the environment into biological signals in eukaryotic cells, I believe that
HA-bacteria likely affect host physiology through the production of small molecules that interact with GPCRs.
The emergence of the SARS-CoV-2 virus represents a worldwide pandemic with no therapeutic drug
treatments. The two Aims of this proposal will result in (1) the identification, isolation, and structure elucidation
of HA-bacteria-encoded metabolites that either interact with diverse GPCRs or inhibit SARS-CoV-2, (2) the
characterization of the gene clusters for these metabolites, and (3) the validation of their production by
colonizing bacteria. These studies will help to illuminate the mechanistic details of how HA-bacteria shape
human health. The human microbiome is reported to influence complex pathophysiological processes ranging
from the regulation of the immune system to the development of the brain and the central nervous system.
Changes in HA-bacterial populations are associated with diseases that affect over 200 million Americans
including obesity, diabetes, inflammatory bowel disease, autism, irritable bowel syndrome, and cirrhosis among
many others. Therapies derived from HA-bacteria have potential utility in controlling diverse basic biological
processes and human diseases.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.celrep.2021.109746
发表时间:
2021-09-21
期刊:
Cell reports
影响因子:
8.8
作者:
[Piscotta FJ, Whitfield ST, Nakashige TG, Estrela AB, Ali T, Brady SF]
通讯作者:
Brady SF
DOI:
10.1016/j.chom.2018.05.013
发表时间:
2018-06-13
期刊:
Cell host & microbe
影响因子:
30.3
作者:
[Milshteyn A, Colosimo DA, Brady SF]
通讯作者:
Brady SF
Discovery and characterization of synthetic bioinformatic natural product anticancer agents
-
批准号:10639302
-
项目类别:
-
资助金额:$42.31万
-
财政年份:2023
-
负责人:SEAN F BRADY
-
依托单位:
Synthetic environmental peptide libraries as a source of novel antibiotics
-
批准号:10394993
-
项目类别:
-
资助金额:$70.34万
-
财政年份:2019
-
负责人:SEAN F BRADY
-
依托单位:
Synthetic environmental peptide libraries as a source of novel antibiotics
-
批准号:10613900
-
项目类别:
-
资助金额:$65.16万
-
财政年份:2019
-
负责人:SEAN F BRADY
-
依托单位:
Discovery of Antibiotics from Soil Microbiomes Using Metagenomics
-
批准号:9906905
-
项目类别:
-
资助金额:$67.8万
-
财政年份:2017
-
负责人:SEAN F BRADY
-
依托单位:
Discovery of Antibiotics from Soil Microbiomes Using Metagenomics
-
批准号:10552394
-
项目类别:
-
资助金额:$59.33万
-
财政年份:2017
-
负责人:SEAN F BRADY
-
依托单位:
Discovery of GPCR-active natural products and their biosynthetic genes from the human associated bacteria
-
批准号:10198774
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2017
-
负责人:SEAN F BRADY
-
依托单位:
Development and application of a functional metagenomic antibiotic discovery pipeline
-
批准号:8932426
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2015
-
负责人:SEAN F BRADY
-
依托单位:
Development and application of a functional metagenomic antibiotic discovery pipeline
-
批准号:9123633
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2015
-
负责人:SEAN F BRADY
-
依托单位:
A minimally invasive synthetic bio-driven approach for natural products discovery
-
批准号:9102130
-
项目类别:
-
资助金额:$223.64万
-
财政年份:2015
-
负责人:SEAN F BRADY
-
依托单位:
A minimally invasive synthetic bio-driven approach for natural products discovery
-
批准号:8867550
-
项目类别:
-
资助金额:$222.98万
-
财政年份:2015
-
负责人:SEAN F BRADY
-
依托单位:
A genomics based strategy for the discovery and study of new signaling systems...
-
批准号:8230238
-
项目类别:
-
资助金额:$42.44万
-
财政年份:2011
-
负责人:SEAN F BRADY
-
依托单位:
A genomics based strategy for the discovery and study of new signaling systems...
-
批准号:7670727
-
项目类别:
-
资助金额:$69.8万
-
财政年份:2009
-
负责人:SEAN F BRADY
-
依托单位:
Discovery and characterization of new natural products from uncultured bacteria
-
批准号:7085064
-
项目类别:
-
资助金额:$29.91万
-
财政年份:2006
-
负责人:SEAN F BRADY
-
依托单位:
Discovery and characterization of new natural products from uncultured bacteria
-
批准号:8495354
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2006
-
负责人:SEAN F BRADY
-
依托单位:
Discovery and characterization of new natural products from uncultured bacteria
-
批准号:8292003
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2006
-
负责人:SEAN F BRADY
-
依托单位:
Discovery and characterization of new natural products from uncultured bacteria
-
批准号:8687669
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2006
-
负责人:SEAN F BRADY
-
依托单位:
Discovery and characterization of new natural products from uncultured bacteria
-
批准号:7683813
-
项目类别:
-
资助金额:$32.0万
-
财政年份:2006
-
负责人:SEAN F BRADY
-
依托单位:
Discovery and characterization of new natural products from uncultured bacteria
-
批准号:7494029
-
项目类别:
-
资助金额:$32.0万
-
财政年份:2006
-
负责人:SEAN F BRADY
-
依托单位:
Discovery and characterization of new natural products from uncultured bacteria
-
批准号:8187304
-
项目类别:
-
资助金额:$34.75万
-
财政年份:2006
-
负责人:SEAN F BRADY
-
依托单位:
Discovery and characterization of new natural products from uncultured bacteria
-
批准号:7925665
-
项目类别:
-
资助金额:$31.68万
-
财政年份:2006
-
负责人:SEAN F BRADY
-
依托单位:
海外基金